4-Bromo-2-(5-bromo-thio-phen-2-yl)-1-[(5-bromo-thio-phen-2-yl)meth-yl]-5,6-dimethyl-1H-benzimidazole.
The title compound, C18H13Br3N2S2, was obtained via the reaction of N-bromo-succinamide with 5,6-dimethyl-2-(thio-phen-2-yl)-1-[(thio-phen-2-yl)meth-yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo-thio-phen-2-yl substituent with a refined major:minor occupancy ratio of 0.876 (7):0.124 (7). The 5-bromo-thio-phen-2-yl mean plane is canted to the benzimidazole plane by 20.0 (4) and 21 (4)° in the major and minor components, respectively. In the crystal, weak C-H⋯N inter-actions link the mol-ecules into infinite C(7) chains along the 21 axes.
Department of Chemistry, State University of New York-College at Geneseo, 1 College Circle, Geneseo, NY 14454, USA.
H Cristina
HC
Geiger
Department of Chemistry, State University of New York-College at Geneseo, 1 College Circle, Geneseo, NY 14454, USA.
James S
JS
Donohoe
Department of Chemistry, State University of New York-College at Geneseo, 1 College Circle, Geneseo, NY 14454, USA.
David K
DK
Geiger